Today, Takeda announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval, under exceptional circumstances, of recombinant ADAMTS13 (rADAMTS13) for treating ADAMTS13 deficiency in both children and adult patients suffering from…
Sanofi to Appeal Delaware Court’s Decision on Zantac Sanofi has expressed disappointment with the recent decision by the State of Delaware court and intends to appeal. The company maintains that there is no reliable scientific evidence linking Zantac to cancer,…
Imagine a contact lens that reshapes the cornea while you sleep, improving your vision. Picture wearing a contact lens equipped with technology to alleviate the strain from increased digital screen time. These innovations and more have been made possible by…
IGC Pharma Begins Patient Enrollment for Phase 2 Alzheimer’s Agitation Trial at Neurostudies IGC Pharma has commenced patient enrollment at Neurostudies, Inc. in Port Charlotte, Florida, for its Phase 2 clinical trial investigating IGC-AD1 as a potential treatment for agitation…
A Journey from Curiosity About Life on Earth to Transformative Therapies at Novartis When I was young, my fascination with science began with the natural world and animals. A BBC Nature presenter and biologist, David Attenborough, was a significant idol…
A biopharmaceutical company specializing in genetic diseases and cancers has unveiled plans to present a series of findings at the 2024 International Symposium on Amyloidosis (ISA) in Rochester, Minnesota, from May 26 to May 30, 2024. BridgeBio Pharma will showcase…
Monkeypox, a viral disease, continues its global impact. Today, the World Health Organization (WHO) unveiled a new strategic framework aimed at guiding efforts to prevent and manage monkeypox outbreaks. The framework targets the elimination of human-to-human transmission and the reduction…
In the latest release of the World Health Statistics by the World Health Organization (WHO), the impact of the COVID-19 pandemic on global life expectancy and healthy life expectancy at birth (HALE) is starkly evident. The pandemic has reversed the…
Eisai has announced its participation in the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (#ASCO24), held both virtually and in-person in Chicago, Illinois from May 31 to June 4. They are presenting research from their oncology portfolio and…
CSL (ASX:CSL; USOTC:CSLLY) and Arcturus Therapeutics (Nasdaq: ARCT) have announced the publication of groundbreaking findings in Nature Communications, revealing the results from a comprehensive phase 1/2/3a/3b study investigating the safety, immune response, and effectiveness of ARCT-154, a pioneering self-amplifying (sa-mRNA)…
Bristol Myers Squibb (NYSE: BMY) has unveiled the Live Your PosSCZible campaign, a nationwide initiative developed in collaboration with the schizophrenia community. The campaign aims to amplify firsthand experiences and equip patients and caregivers with educational tools, community connections, and…
Bristol Myers Squibb (NYSE: BMY) has unveiled the Live Your PosSCZible campaign, a nationwide initiative in collaboration with the schizophrenia community. The campaign aims to amplify personal experiences, offering educational resources, community connections, and peer support to empower patients and…
